ABBOTT PARK, Ill., April 18, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the TECNIS ® Toric 1-Piece intraocular lens (IOL) has received U.S. Food and Drug Administration (FDA) ...

The US Food and Drug Administration (FDA) has just approved Abbott's Tecnis Toric 1-piece intraocular lens (IOL) to treat preexisting astigmatism in patients with cataract. The blurry vision of ...

Please provide your email address to receive an email when new articles are posted on . In a study, the Tecnis Eyhance toric II IOL had good rotational stability over 3 months, significant reduction ...

Johnson & Johnson Vision (JNJ) has received approval in the US for TECNIS Synergy and TECNIS Synergy Toric II IOLs. In Canada, it received approval for TECNIS Synergy Toric II IOLs. This ...

Please provide your email address to receive an email when new articles are posted on . With advancing technology, cataract surgery is now less invasive, resulting in better recovery and outcomes. Not ...

The next-generation presbyopia-correcting intraocular lens (PC-IOL) offers cataract patients the widest^ range of continuous^^ vision and best near vision among leading PC-IOLs^^^^ 1,2,3,4,5 Now ...

Intraocular lenses are implanted in a patient's eye after the removal of the natural lens that has become clouded by a cataract. Unlike conventional IOLs, the TECNIS Toric 1-Piece IOL can correct a ...

The new approvals are the latest in Johnson & Johnson’s IOLs; the Company claims the new TECNIS Eyhance IOL can slightly extend the depth of focus and deliver better image contrast. The Food and Drug ...

TECNIS Odyssey IOL offers higher tolerance to residual refractive errors, enabling surgeons to deliver consistent and reliable patient outcomes. 5¶ Experience the ...

The new full visual range* 1 IOL enables 93% of patients to become free from glasses at all distances.** 2 *** With best-in-class image contrast and low-light performance, #~3,4,5 TECNIS Odyssey IOL ...

Abbott ABT today announced that the TECNIS Toric 1-Piece intraocular lens (IOL) has received U.S. Food and Drug Administration (FDA) approval and is launching in the United States for the treatment of ...